Patent · US Active

Solid forms comprising (1E, 4E)-2-amino-N,N-dipropyl-8-(4-(pyrrolidine-1-carbonyl)phenyl)-3H-benzo[B]azepine-4-carboxami compositions thereof, and uses thereof

US10604510B2 · kind B2 · utility

0Cited by

3References

13Claims

0Family size

Assignee

CELGENE CORPORATION · US

Inventors

Hon-Wah Man · Princeton, US
Timothy D. Fitzpatrick · Boulder, US
Anthony Joseph Frank · Easton, US
Ying Li · Millburn, US
Xiaoling Lu · Whippany, US
Marie Georges Beauchamps · Dover, US
Antonio Christian Ferretti · Summit, US

Key dates

Filing date	Sep 13, 2019
Grant date	Mar 31, 2020
Priority date	—
Expiry date	Sep 13, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are compositions including the crystalline forms of (1E, 4E)-2-amino-N,N-dipropyl-8-(4-(pyrrolidine-1-carbonyl)phenyl)-3H-benzo[b]azepine-4-carboxamide (“Compound A”), methods of making the crystalline forms, and methods of using the crystalline forms for the treatment of diseases, including, for example, cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.